{"answers":{"affected":"It affects 1 product.","exploited":"It is not confirmed as exploited in the wild, but public exploit code for CVE-2024-44837 exists.","fix":"No fix has been published for CVE-2024-44837 yet. Limit exposure of the affected software until one is available.","what":"CVE-2024-44837 is a medium-severity cross-site scripting vulnerability in n/a, published on 6 Sep 2024. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2024-44837 and fix it if it is affected.\n\nWhat it is: CVE-2024-44837 is a medium-severity cross-site scripting vulnerability in n/a, published on 6 Sep 2024. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.\nExploitation: It is not confirmed as exploited in the wild, but public exploit code for CVE-2024-44837 exists.\n\nAffected product: n/a. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2024-44837/ (Markdown: https://insights.sbomify.com/CVE-2024-44837/index.md)","id":"CVE-2024-44837","markdown":"https://insights.sbomify.com/CVE-2024-44837/index.md","name":"CVE-2024-44837","record":{"aliases":["GHSA-vxpg-8v7f-78w3"],"analysis":{"component_type":"web_application","fix_type":"no_fix_stated","impacts":["code_execution"],"network_reachable":"yes","non_default_config":false,"product_category":"Drug web application","requires_auth":"low_privilege","summary":"Attackers can execute arbitrary web scripts via a crafted payload in the user parameter of the Drug application.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"mitre","cpe":[{"product":"drug","vendor":"deathbreak"}],"cvss":{"score":5.4,"severity":"medium","source":"cisa-adp","vector":"CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"A cross-site scripting (XSS) vulnerability in the component \\bean\\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"weaponised"},"has_fix":null,"headline":"Cross-site scripting in n/a","id":"CVE-2024-44837","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2024"},"n_packages":0,"n_references":1,"next":{"headline":"SQL injection in n/a","id":"CVE-2024-44838"},"packages":[],"prev":{"headline":"Path traversal in n/a","id":"CVE-2024-44825"},"products":["n/a"],"published":"2024-09-06","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"poc","technical_impact":"partial"},"state":"PUBLISHED","updated":"2024-09-06","vendors":["n/a"]},"summary":"Attackers can execute arbitrary web scripts via a crafted payload in the user parameter of the Drug application.","url":"https://insights.sbomify.com/CVE-2024-44837/"}